IMDX icon

Insight Molecular (IMDX)

NASDAQ

$3.77

$0.32 (

+9.28%

)

1D
5D
1M
6M
1Y
5Y
Market closed

IMDX: $3.77 / ₿ 0.0001 BTC / 5621 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$3.45
$2.33 - $8.51
$121.27M
-0.98
$3.45
$296,093.66
32.17M
$3.15 - $9.00
$3.28 - $3.79
Yes

What is Insight Molecular (IMDX)?

Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.

The Insight Molecular (IMDX) stock price has been rising

The Insight Molecular Diagnostics Inc. Common Stock (IMDX) stock price today is $3.77, reflecting a +9.28% move since the market opened. The company’s market capitalization stands at $121.27M, with a daily trading volume of $296.09K shares. For investors tracking price trends, Insight Molecular Diagnostics Inc. Common Stock stock has ranged between $3.28 and $3.79 today. The previous closing price was $3.45.

Get started with Insight Molecular (IMDX)

Ready to get started? Follow the steps below, or read our guide on how to buy Insight Molecular stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy IMDX

Search for IMDX in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy IMDX.

IMDX FAQs

IMDX is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

IMDX is in the Diagnostics & Research industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, Insight Molecular Diagnostics Inc. Common Stock (IMDX) has traded between a low of $2.33 and a high of $8.51.

IMDX is in the Medical Diagnostics & Research industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in Insight Molecular? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
IMDX icon
IMDX

Only available to USA clients through the Kraken app
or Kraken Pro.

Get the Kraken Pro app and buy Insight Molecular in minutes

Kraken App QR Code

Explore other stocks

Most active

Explore the most-traded stocks today

AIXI icon

AIXI

SKYQ icon
NVDA icon

NVDA

Top gainers

Browse today’s biggest stock market winners

Top losers

Compare the worst-performing stocks of 
the day

ARVLF icon

ARVLF

SDCCQ icon
YOTAR icon

YOTAR

APCXW icon
LPCN icon

LPCN

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.